- Home
- ICLR vs FWONA Comparison
ICLR vs FWONA Comparison
Compare ICLR & FWONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- FWONA
- Stock Information
- Founded
- ICLR 1990
- FWONA 1950
- Country
- ICLR Ireland
- FWONA United States
- Employees
- ICLR N/A
- FWONA N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- FWONA Broadcasting
- Sector
- ICLR Health Care
- FWONA Industrials
- Exchange
- ICLR Nasdaq
- FWONA Nasdaq
- Market Cap
- ICLR 17.2B
- FWONA 19.1B
- IPO Year
- ICLR 1998
- FWONA N/A
- Fundamental
- Price
- ICLR $207.51
- FWONA $85.36
- Analyst Decision
- ICLR Strong Buy
- FWONA Buy
- Analyst Count
- ICLR 9
- FWONA 2
- Target Price
- ICLR $286.67
- FWONA $77.00
- AVG Volume (30 Days)
- ICLR 1.2M
- FWONA 150.6K
- Earning Date
- ICLR 02-19-2025
- FWONA 11-07-2024
- Dividend Yield
- ICLR N/A
- FWONA N/A
- EPS Growth
- ICLR 44.49
- FWONA N/A
- EPS
- ICLR 8.99
- FWONA 1.15
- Revenue
- ICLR $8,306,823,000.00
- FWONA $3,716,000,000.00
- Revenue This Year
- ICLR $3.96
- FWONA $20.86
- Revenue Next Year
- ICLR $2.88
- FWONA $10.07
- P/E Ratio
- ICLR $23.09
- FWONA $83.42
- Revenue Growth
- ICLR 3.63
- FWONA 35.32
- 52 Week Low
- ICLR $183.38
- FWONA $55.86
- 52 Week High
- ICLR $347.72
- FWONA $87.42
- Technical
- Relative Strength Index (RSI)
- ICLR 42.59
- FWONA 61.00
- Support Level
- ICLR $201.38
- FWONA $83.15
- Resistance Level
- ICLR $211.76
- FWONA $87.42
- Average True Range (ATR)
- ICLR 6.76
- FWONA 2.33
- MACD
- ICLR 0.71
- FWONA -0.14
- Stochastic Oscillator
- ICLR 31.16
- FWONA 65.15
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About FWONA Liberty Media Corporation Series A Liberty Formula One
Formula One Group controls the exclusive commercial and promotional rights to the FIA Formula One World Championship series, and the monetization of those rights is the primary business of the group. The firm is responsible for development and promotion of the Formula One race series in concert with its three partners: the FIA (the regulatory body), the teams that participate in the series, and the series' commercial partners, which include the race promoters, broadcasters, sponsors, and advertisers. The F1 schedule in 2023 will encompass 23 races held on five continents. Formula One Group is a subsidiary of Liberty Media, which purchased the firm in January 2017. Formula One stock is a tracking stock for the assets under Formula One Group with Liberty Media.